Carolinas HealthCare System monitors ICUs in 10 of its hospitals from a command center near Charlotte. The command center is staffed 24/7 with a rotating crew of 7 to 9 nurses and doctors who specialize in critical care.
Recovering from pneumonia is an unusual experience in the 10-bed intensive care unit (ICU) at the Carolinas HealthCare System hospital in rural Lincolnton, North Carolina. The small hospital has its regular staff in Lincolnton, but Richard Gilbert, one of the ICU patients, has an extra nurse who is 45 miles away.
That registered nurse, Cassie Gregor, sits in front of 6 computer screens in an office building. She wears a headset, and her voice is piped into Gilbert’s room via computer speakers. A doorbell sounds before the camera turns on, alerting Gilbert that the nurse is looking in. They chit-chat as Gregor monitors Gilbert’s vital signs. The nurse asks how he’s feeling and if there’s anything he needs.
Carolinas HealthCare System monitors ICUs in 10 of its hospitals from this command center near Charlotte. The command center is staffed 24/7 with a rotating crew of 7 to 9 nurses and doctors who specialize in critical care. Everyone on the team also does bedside shifts.
Read more at Kaiser Health News: http://bit.ly/1zVMz9Q
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Higher Weight-Adjusted Waist Index Tied to Greater Mortality Risk in Patients With Osteoarthritis
April 23rd 2025Researchers consider the weight-adjusted waist index a more precise predictor of mortality risk in patients with osteoarthritis than traditional obesity measures, like body mass index.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen